SHPAX
Price
$19.13
Change
+$0.23 (+1.22%)
Updated
Jun 24 closing price
Net Assets
9.98M
VGHAX
Price
$73.04
Change
+$0.91 (+1.26%)
Updated
Jun 24 closing price
Net Assets
36.03B
Interact to see
Advertisement

SHPAX vs VGHAX

Header iconSHPAX vs VGHAX Comparison
Open Charts SHPAX vs VGHAXBanner chart's image
Saratoga Health & Biotechnology A
Price$19.13
Change+$0.23 (+1.22%)
VolumeN/A
Net Assets9.98M
Vanguard Health Care Adm
Price$73.04
Change+$0.91 (+1.26%)
VolumeN/A
Net Assets36.03B
SHPAX vs VGHAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SHPAX vs. VGHAX commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SHPAX is a Buy and VGHAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGHAX has more cash in the bank: 36B vs. SHPAX (9.98M). VGHAX pays higher dividends than SHPAX: VGHAX (0.95) vs SHPAX (0.00). SHPAX was incepted earlier than VGHAX: SHPAX (26 years) vs VGHAX (24 years). SHPAX (2.72) is less costly to investors than VGHAX (0.32). VGHAX is a more actively managed with annual turnover of: 29.00 vs. SHPAX (17.00). SHPAX has a lower initial minimum investment than VGHAX: SHPAX (250) vs VGHAX (50000). SHPAX annual gain was more profitable for investors over the last year : -6.90 vs. VGHAX (-21.79). SHPAX return over 5 years is better than : -3.72 vs. VGHAX (-17.54).
SHPAXVGHAXSHPAX / VGHAX
Total Expense Ratio2.720.32850%
Annual Report Gross Expense Ratio2.720.32850%
Fund Existence26 years24 years-
Gain YTD0.585-6.191-9%
Front Load6%N/A-
Min. Initial Investment250500001%
Min. Initial Investment IRAN/AN/A-
Net Assets9.98M36B0%
Annual Yield % from dividends0.000.95-
Returns for 1 year-6.90-21.7932%
Returns for 3 years-4.55-14.5631%
Returns for 5 years-3.72-17.5421%
Returns for 10 years-41.07-27.58149%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDERX22.640.01
+0.06%
Federated Hermes Equity Income R
GQLOX33.90N/A
N/A
GMO Quality VI
MDOEX11.02N/A
N/A
Morgan Stanley Developing Opportunity I
UGLSX75.03N/A
N/A
JHancock U.S. Global Leaders Growth R6
MSCFX27.48N/A
N/A
Mairs & Power Small Cap